Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allarity Therapeutics, Inc. | President and Chief Development Officer | Common Stock | 118K | $250K | $2.11 | Sep 30, 2024 | Direct |
IN8BIO, INC. | Director | Common Stock | 4.55K | $4.69K | $1.03 | Dec 13, 2023 | Direct |
IN8BIO, INC. | Director | Stock Option (right to buy) | 33.7K | Jun 12, 2024 | Direct | ||
IN8BIO, INC. | Director | Series A Warrants (right to buy) | 2.05K | Dec 13, 2023 | Direct | ||
IN8BIO, INC. | Director | Series B Warrants (right to buy) | 2.05K | Dec 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALLR | Allarity Therapeutics, Inc. | Sep 30, 2024 | 1 | $250K | 4 | Oct 1, 2024 | President and Chief Development Officer |
ALLR | Allarity Therapeutics, Inc. | Sep 30, 2024 | 0 | $0 | 3 | Oct 1, 2024 | President and Chief Development Officer |
INAB | IN8BIO, INC. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
INAB | IN8BIO, INC. | Dec 13, 2023 | 3 | $0 | 4 | Dec 15, 2023 | Director |
INAB | IN8BIO, INC. | Sep 13, 2023 | 1 | $2.38K | 4 | Sep 15, 2023 | Director |
INAB | IN8BIO, INC. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
INAB | IN8BIO, INC. | May 1, 2023 | 1 | $0 | 4 | May 3, 2023 | Director |
INAB | IN8BIO, INC. | May 1, 2023 | 0 | $0 | 3 | May 3, 2023 | Director |